CSIMarket
 
Poseida Therapeutics Inc   (PSTX)
Other Ticker:  
 
 
Price: $3.2200 $-0.02 -0.617%
Day's High: $3.44 Week Perf: -5.57 %
Day's Low: $ 3.17 30 Day Perf: -13.21 %
Volume (M): 935 52 Wk High: $ 4.27
Volume (M$): $ 3,009 52 Wk Avg: $2.65
Open: $3.18 52 Wk Low: $1.54



 Market Capitalization (Millions $) 296
 Shares Outstanding (Millions) 92
 Employees -
 Revenues (TTM) (Millions $) 52
 Net Income (TTM) (Millions $) -132
 Cash Flow (TTM) (Millions $) -139
 Capital Exp. (TTM) (Millions $) 3

Poseida Therapeutics Inc
Poseida Therapeutics Inc is a biotechnology company that focuses on developing gene therapies for the treatment of various diseases, including cancer and genetic disorders. The company's mission is to provide innovative and potentially curative treatments using its proprietary gene engineering platform, which enables precise and targeted genetic modifications. Poseida Therapeutics utilizes cutting-edge technology and expertise to develop and commercialize its gene therapies, with the aim of improving patient outcomes and quality of life. The company is committed to advancing the field of gene therapy through research and collaboration with other organizations.


   Company Address: 9390 Towne Centre Drive San Diego 92121 CA
   Company Phone Number: 779-3100   Stock Exchange / Ticker: NASDAQ PSTX
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Poseida Therapeutics Inc

Poseida Therapeutics Inc's Third Quarter 2023: A Devastating Blow to the Biotech Giant

Poseida Therapeutics Inc is a biotechnology company that specializes in gene and cell therapies. However, their recent third quarter financial report of 2023 has shown significant declines in revenue and earnings, leading to concerns about the company's performance.
According to the report, Poseida Therapeutics Inc experienced a staggering 91.959% decrease in revenue, which plummeted to $9.35 million compared to the same period in the previous year. This steep decline in revenue is a cause for alarm and raises questions about the company's ability to generate sustainable income. Additionally, the shortfall per share has increased to $-0.35, indicating a deterioration in the company's financial health.

Poseida Therapeutics Inc

Poseida Therapeutics Inc Surpasses Expectations with Significant Improvement in Financial Performance

Poseida Therapeutics Inc (PSTX) has seen a significant drop of -29.39% in its shares over the past three months. However, there has been a recent improvement, with shares rising by 4.22% in the last 30 days. Additionally, the company's shares currently trade 12.3% above its 52-week low.
Taking a closer look at the financial performance of Poseida Therapeutics Inc, it is evident that the company has made positive strides. In the financial period ending June 30, 2023, the company reported a decrease in loss per share, from $-0.69 to $-0.32 compared to the previous year. Moreover, the company managed to improve its income per share from $-0.45 in the previous reporting season.

Poseida Therapeutics Inc

Poseida Therapeutics Inc's First Quarter 2023 Sees Dramatic Decline with Revenue Plummeting by 66.89%

Poseida Therapeutics Inc, a leader in the biotechnology industry, just reported its financial results for the period between January to March 31, 2023. Unfortunately, the numbers are not encouraging.
Revenue took a massive hit this quarter, falling by -66.89% to $10.34 million. This is a sharp decrease from the $31.11 million the company reported during the same period last year. Furthermore, the company's net loss per share has extended at $-0.45, up from $-0.34 per share during the same period last year.






 

Poseida Therapeutics Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com